Sarborg Limited, an AI-driven drug development technology company, announced the completion of a $10 million seed round led by Corvus Capital. The company intends to use the new funds to expand AI agents, cybernetic algorithms and machine learning capabilities in other industries, and to explore equity, tokenized securities and cryptocurrency-based blockchain technology in multiple verticals.